Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Sunday 05.04.2020 at 10:00 AM CEST
Settings

Settings

1. WO1996003132 - SYNERGISTIC PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAMCINOLONE ACETONIDE AND HALCINONIDE

Publication Number WO/1996/003132
Publication Date 08.02.1996
International Application No. PCT/US1995/009544
International Filing Date 27.07.1995
Chapter 2 Demand Filed 27.02.1996
IPC
A61K 31/57 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
57substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
CPC
A61K 31/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
57substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
Applicants
  • PSORIAL, L.L.C. [US/US]; Suite 2507 375 Park Avenue New York, NY 10152, US (AllExceptUS)
  • CHRIKI, Georges [IL/IL]; IL (UsOnly)
Inventors
  • CHRIKI, Georges; IL
Agents
  • ELMORE, Carolyn, S. ; Hamilton, Brook, Smith & Reynolds, P.C. Two Militia Drive Lexington, MA 02173, US
Priority Data
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) SYNERGISTIC PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAMCINOLONE ACETONIDE AND HALCINONIDE
(FR) COMPOSITIONS PHARMACEUTIQUES A EFFET SYNERGIQUE A BASE D'ACETONIDE DE TRIAMCINOLONE ET DE HALCINONIDE
Abstract
(EN)
A pharmaceutical composition comprises a synergistic combination of at least about 0.01 % by wt. triamcinolone acetonide and at least about 0.01 % by wt. halcinonide as active ingredients therein, in combination with a pharmaceutically acceptable carrier.
(FR)
Une composition pharmaceutique est constituée d'une association synergique contenant, comme principes actifs, au moins environ 0,01 % en poids d'acétonide de triamcinolone et au moins environ 0,01 % en poids de halcinonide, en association avec un excipient pharmaceutiquement acceptable.
Also published as
Latest bibliographic data on file with the International Bureau